As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 9/29/20  Orbimed Advisors LLC              4          Dir.,%Own.² 1:22K  Prelude Therapeutics Inc.         DONNELLEY FIN… File16/FA 
          OrbiMed Capital GP VI LLC
          Orbimed Capital LLC
 9/29/20  Nextech V Oncology SCS, SICAV-SIF 4          Other²      1:14K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          Bleyer Dalia
          Detournay Philippe
          Lips Thomas
          Nextech V GP S.A R.L.
 9/29/20  Wellington Biomedical Inno…  I LP 4          Other²      1:6K   PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Euclidean Capital LLC             4          Other²      1:24K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          Chhabra Ashvin
          Greenland A LLC
          Greenland FP LLC
          Greenland NFP B Ltd.
          Greenland NFP LLC
          Simons James H
          Simons Marilyn
 9/29/20  Double Epiphany, LLC              4          Other²      1:3K   PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Levine Alison                     4          Other²      1:3K   PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Dawson Samantha                   4          Other²      1:3K   PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Orbimed Advisors LLC              4          10% Owner²  1:11K  CalciMedica, Inc.                 DONNELLEY FIN… File16/FA 
          OrbiMed Capital GP VI LLC
 9/29/20  Boxer Capital, LLC                4          Other²      1:20K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          Boxer Asset Management Inc.
          Davis Aaron I.
          Lewis Joseph
          MVA Investors, LLC
 9/29/20  Orbimed Advisors LLC              4          Dir.,%Own.² 1:26K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          OrbiMed Capital GP V LLC
          Orbimed Capital LLC
          OrbiMed Genesis GP LLC
 9/29/20  Thompson Peter A.                 4          Dir.,%Own.² 1:22K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Schroeder Thilo                   4          Dir.,%Own.² 1:9K   PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Interwest Partners X LP           4          10% Owner²  1:20K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          Desai Keval
          InterWest Management Partners X, LLC
          Kliman Gilbert H
          Nasr Khaled
 9/29/20  Oronsky Arnold L                  4          Dir.,%Own.² 1:15K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
 9/29/20  Nextech V Oncology SCS, SICAV-SIF 3/A        10% Owner²  1:11K  PMV Pharmaceuticals, Inc.         DONNELLEY FIN… File16/FA 
          Bleyer Dalia
          Detournay Philippe
          Lips Thomas
          Nextech V GP S.A R.L.
 9/29/20  Ra Capital Management, L.P.       4          10% Owner²  1:11K  PMV Pharmaceuticals, Inc.         Toppan Merrill/FA        
          Kolchinsky Peter
          Shah Rajeev M.
 9/29/20  PMV Pharmaceuticals, Inc.         8-K:5,7,9   9/29/20    4:208K                                   Donnelley … Solutions/FA 

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.